Archives: Search / 2018 / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010
Dec 11, 2018 --Company Expects to be Well within Its Financial Covenants through the Maturity Date of the Term A Loans-- Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an amendment of its credit agreement effecting the term A loans thereunder (Term A Loans) to provide the company greater... More |
Dec 5, 2018 Lannett Company, Inc. (NYSE: LCI) today announced that the company will present at the BMO Capital Markets 2018 Prescription for Success Healthcare Conference on December 12, 2018 at 2:40 p.m.... More |
Nov 12, 2018 --Lannett Locks in $50 Million of Gross Profit for 16-Week Period-- Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an agreement with Amneal Pharmaceuticals, Inc. (Amneal) with regard to Levothyroxine Sodium Tablets USP. Under the... More |
Nov 7, 2018 - Fiscal 2019 First Quarter Net Sales and Adjusted Net Income Ahead of Expectations Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2019 first quarter ended September 30, 2018. "For the fiscal 2019 first quarter, net sales and adjusted net income... More |
Nov 7, 2018 Product Launches, Cost Savings
|
Nov 6, 2018 --Company Has Commenced Launch of Clarithromycin and Expects to Begin Marketing Entacapone In Early Calendar Year 2019-- Lannett Company, Inc. (NYSE: LCI) today announced that it has expanded its agreement with Sunshine Lake LLC, the U.S. subsidiary of the HEC Pharm Group (HEC) of China, to be the exclusive... More |
Nov 1, 2018 --Launch Commenced; First-Time Generic Launch of Levitra®-- Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an agreement with Rivopharm SA to be the exclusive U.S. distributor of Vardenafil Hydrochloride Tablets, 2.5 mg, 5 mg, 10... More |
Nov 1, 2018 Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2019 first quarter on Wednesday, November 7, 2018, after the market closes. Lannett... More |
Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an agreement with Adare Pharmaceuticals, Inc., to be the exclusive U.S. distributor of Dexmethylphenidate Hydrochloride... More |
Oct 8, 2018 Lannett Company, Inc. (NYSE: LCI) today announced that it has engaged and/or expanded the role of existing advisors to assist in evaluating a range of alternatives regarding the company's debt and... More |